As of June 2, 2023, Kevin Fischbeck, an analyst from Bank of America Securities, has recently upgraded Universal Health Services (NYSE: UHS) from a ‘neutral’ to a ‘buy’ rating. He has also set a price target of $163.00 for the company, indicating his belief that UHS is currently undervalued and has the potential to increase in value.
Fischbeck’s recommendation to buy the stock is a positive sign for investors who are looking for potential growth opportunities in the healthcare industry. Universal Health Services is a healthcare management company that operates hospitals and other healthcare facilities in both the United States and the United Kingdom. Its diverse portfolio of healthcare services and facilities makes it a strong player in the industry, and Fischbeck’s upgrade suggests that the company is well-positioned for future success.
Universal Health Services (UHS) Shows Promising Outlook for Future Earnings Growth on June 2, 2023
On June 2, 2023, Universal Health Services (UHS) opened at $134.05, up 2.23% from its previous close of $131.14. The day’s range was between $134.04 and $136.83, with a volume of 248,913 shares traded.
UHS has a market cap of $9.0B, and is a part of the Health Services sector, specifically in the Hospital/Nursing Management industry. The company has reported a revenue growth of 5.99% in the last year, but its earnings growth for the same period was -23.03%. This year, UHS has shown a slight improvement in earnings growth, with a reported increase of 2.70%. However, the company’s projected earnings growth for the next five years is at a healthy rate of 9.01%.
UHS has a P/E ratio of 14.5, which is lower than the industry average of 24.8. The company’s price/sales ratio is 0.78, while its price/book ratio is 1.53. These ratios suggest that UHS is undervalued compared to its peers in the industry.
In comparison to other companies in the industry, UHS has performed well on June 2, 2023.
UHS is set to report its earnings on July 24, 2023, with an EPS forecast of $2.42 for this quarter. The company reported an annual revenue of $13.4B last year, with a net profit of $674.9M and a net profit margin of 5.04%.
UHS is headquartered in King of Prussia, Pennsylvania, and does not have any executives to display. Overall, UHS has shown a positive performance on June 2, 2023, with a significant increase in stock and a promising outlook for future earnings growth.
Investing in Universal Health Services Inc: A Stable Outlook and Positive Growth Forecasts
Universal Health Services Inc (UHS) is a leading healthcare provider that operates hospitals, behavioral health facilities, and outpatient clinics across the United States. As of June 2, 2023, UHS stock was trading at $136.26, with a market capitalization of $15.5 billion.
According to CNN Money, 16 analysts have provided 12-month price forecasts for UHS stock, with a median target of $153.50. The consensus among 19 polled investment analysts is to hold UHS stock. This rating has remained unchanged since June, indicating a stable outlook for the company.
UHS is scheduled to report its current quarter earnings on July 24, 2023. The company’s earnings per share for the current quarter are $2.42, with sales of $3.5 billion.
Overall, UHS stock has shown steady growth over the past year, with a 52-week range of $105.22 to $142.22. The company’s strong financial performance, coupled with its position as a leading healthcare provider, suggests a positive outlook for UHS stock in the long term.
Investors looking to invest in UHS stock should consider the company’s financial performance, growth prospects, and industry trends. With a stable consensus rating and positive growth forecasts, UHS stock may be a good investment for those looking to diversify their portfolio.
Source: beststocks.com
